OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Diabetic Medicines

Diabetic Medicines


As per available reports about 12 Relevant Journals, 16 Conferences, 23 National Symposiums are presently dedicated exclusively to Diabetes and about 1067 open acess articles are being published on breathing disorder.

Diabetes means your blood glucose, or blood sugar, levels are too high. If you can't control your diabetes with wise food choices and physical activity, you may need diabetes medicines. The kind of medicine you take depends on your type of diabetes, your schedule, and your other health conditions. With type 1 diabetes, your pancreas does not make insulin. Insulin is a hormone that helps glucose get into your cells to give them energy. Without insulin, too much glucose stays in your blood. If you have type 1 diabetes, you would require insulin intake from time to time. Type 2 diabetes the most common type, can start when the body doesn't use insulin as it should. If your body can't keep up with the need for insulin, you may need to take pills. Along with meal planning and physical activity, diabetes pills help people with type 2 diabetes or gestational diabetes keep their blood glucose levels on target. Several kinds of pills are available. Each works in a different way. Many people take two or three kinds of pills. Some people take combination pills. Combination pills contain two kinds of diabetes medicine in one tablet. Some people take pills and insulin.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance

Once diagnosed with diabetes, the patients along with their healthcare professionals work together to develop a treatment plan to help achieve blood glucose levels within a target range. The programs might include nutrition, exercise along with a combination of medications which provide you with the knowledge and skills to understand the key aspects of treatment plan including blood glucose monitoring and medication therapy. A good knowledge of your health programme helps you to prevent any complications while your treatment and managing high and low blood glucose.

Old Content

Diabetes means your blood glucose, or blood sugar, levels are too high. If you can't control your diabetes with wise food choices and physical activity, you may need diabetes medicines. The kind of medicine you take depends on your type of diabetes, your schedule, and your other health conditions.

With type 1 diabetes, your pancreas does not make insulin. Insulin is a hormone that helps glucose gets into your cells to give them energy. Without insulin, too much glucose stays in your blood. If you have type 1 diabetes, you will need to take insulin.

Type 2 diabetes, the most common type, can start when the body doesn't use insulin as it should. If your body can't keep up with the need for insulin, you may need to take pills. Along with meal planning and physical activity, diabetes pills help people with type 2 diabetes or gestational diabetes keep their blood glucose levels on target. Several kinds of pills are available. Each works in a different way. Many people take two or three kinds of pills. Some people take combination pills. Combination pills contain two kinds of diabetes medicine in one tablet. Some people take pills and insulin.

Drug treatment for Type 1 diabetes:

Insulin injected subcutaneously is the first-line treatment of type 1 diabetes mellitus (DM). The different types of insulin vary with respect to onset and duration of action. Short-, intermediate-, and long-acting insulins are available. Short-acting and rapid-acting insulins are the only types that can be administered intravenously (IV). Human insulin currently is the only species of insulin available in the United States; it is less antigenic than the previously used animal-derived varieties.

Rapid-acting insulins are used whenever a rapid onset and short duration are appropriate (eg, before meals or when the blood glucose level exceeds target and a correction dose is needed). Rapid-acting insulins are associated with less hypoglycemia than regular insulin.  

Currently, short-acting insulins are less commonly used than the rapid-acting insulins in patients with type 1 DM. They are used when a slightly slower onset of action or a greater duration of action is desired.

Intermediate-acting insulins have a relatively slow onset of action and a relatively long duration of action. They are usually combined with faster-acting insulins to maximize the benefits of a single injection.

Long-acting insulin has a very long duration of action and, when combined with faster-acting insulin’s, provides better glucose control for some patients. In patients with type 1 DM, they must be used in conjunction with rapid-acting or short-acting insulin given before meals.

Premixed insulins contain a fixed ratio of rapid-acting insulin with longer-acting insulin, which can restrict their use. Premixed insulin is usually not recommended in type 1 DM patients, because of their need for frequent adjustments of pre-meal insulin doses

Types of Diabetes Pills for Type 2 Diabetes

Diabetes pills are grouped in categories. There are several categories of diabetes pills. Each works differently.

Sulfonylureas: These diabetes pills lower blood sugar by causing the pancreas to release more insulin. The first drugs of this type that were developed -- Dymelor (acetohexamide), Diabinese (chlorpropamide), Orinase (tolbutamide), and Tolinase (tolazamide) -- are not as widely used since they tend to be less potent and shorter-acting drugs than the newer sulfonylureas. They include Glucotrol (glipizide), Glucotrol XL (extended release), DiaBeta (glyburide), Micronase (glyburide), Glynase PresTab (glyburide), and Amaryl (glimepiride). These drugs can cause a decrease in the hemoglobin A1c (HbA1c) of up to 1%-2%.

Biguanides: These diabetes pills improve insulin's ability to move sugar into cells especially into the muscle cells. They also prevent the liver from releasing stored sugar. Biguanides should not be used in people who have kidney damage or heart failure because of the risk of precipitating a severe build-up of acid (called lactic acidosis) in these patients. Biguanides can decrease the HbA1c 1%-2%. An example includes metformin (Glucophage, Glucophage XR, Riomet, Fortamet, and Glumetza).

Thiazolidinediones: These diabetes pills improve insulin's effectiveness in muscle and in fat tissue. They lower the amount of sugar released by the liver and make fat cells more sensitive to the effects of insulin. Actos (pioglitazone) and Avandia (rosiglitazone) are the two drugs of this class. A decrease in the HbA1c of 1%-2% can be seen with this class of oral diabetes medications. These drugs may take a few weeks before they have an effect in lowering blood sugar. All patients using Avandia must review and fully understand the risks to the heart.

Alpha-glucosidase inhibitors: including Precose (acarbose) and Glyset (miglitol). These drugs block enzymes that help digest starches, slowing the rise in blood sugar. These diabetes pills may cause diarrhea or gas. They can lower hemoglobin A1c by 0.5%-1%.

Meglitinides: including Prandin (repaglinide) and Starlix (nateglinide). These diabetes medicines lower blood sugar by stimulating the pancreas to release more insulin. The effects of these diabetes pills depend on the level of glucose. They are said to be glucose dependent. High sugars make this class of diabetes medicines release insulin. This is unlike the sulfonylureas that cause an increase in insulin release, regardless of glucose levels, and can lead to hypoglycemia.

Combination Therapy: There are several combination diabetes pills that combine two medications into one tablet. One example of this is Glucovance, which combines glyburide (a sulfonylurea) and metformin. Others include Metaglip, which combines glipizide (a sulfonylurea) and metformin, and Avandamet, which uses both metformin and rosiglitazone (Avandia) in one pill. Kazano (alogliptin and metformin) and Oseni (alogliptin plus pioglitazone) are other examples.

Studies have shown that some diabetes pills may help prevent diabetes and diabetes-related complications. Both metformin and Precose have been shown to reduce a person's risk of developing type 2 diabetes, particularly when combined with lifestyle changes such as a proper diet and regular exercise program. Actos has been shown to reduce the risk of heart attack, stroke, and premature death in those with type 2 diabetes. Researchers continue to look into the preventative benefits of other medications.

Side Effects of Oral Diabetes Drugs

Side effects of first- and second-generation sulfonylureas include:

  1. Hypoglycemia (low blood sugar)
  2. Upset stomach
  3.  Skin rash or itching
  4. Weight gain

Side effects for biguanide medications include:

  1. Upset stomach (nausea, diarrhea)
  2. Metallic taste in mouth

Side effects for thiazolidinediones are rare but may include:

  1. Elevated liver enzymes
  2. Liver failure
  3. Respiratory infection
  4. Headache
  5. Fluid retention

Side effects for alpha-glucosidase inhibitors include:

Stomach upset (gas, diarrhea, nausea, cramps)

Side effects of meglitinides include:

  1. Hypoglycemia (low blood sugar)
  2. Stomach upset

Side effects of Invokana (canagliflozin, the SGLT2 inhibitor)

  1. Vaginal yeast infections
  2. Urinary tract infections
  3. Dizziness, fainting

Market Analysis

In a grim reminder of the rise of lifestyle diseases, particularly diabetes, an anti-diabetic molecule has for the first time become the largest-selling formulation in the domestic pharma retail market. Widely-prescribed anti-diabetic drugs (glimepiride plus metformin) clocked sales of Rs 105 crore, surpassing the anti-infective therapy at Rs 103 crore, in the pharma retail market valued at Rs 6,636 crore, in May this year. Analysts tracking the market said the anti-infective therapy had always been ranked on top. The primary reason for the anti-diabetic molecule taking the lead is because of its faster growth, as well as the anti-infective molecule coming under price control. 


List of best International Conferences:

  1. 4th Nephrology Conference
    September 14-16, 2015, USA
  2. 3rd Endocrinology  Conference
    November  02-04,  2015, USA
  3. 11th Targeting  Diabetes  Conference
    October  17-19,  2016, Malaysia
  4. 6th Endocrinology  Conference
    November  28-30,  2016;  USA
  5. 6th Diabetes Conference
    November  02-04,  2015, UAE
  6. 8th Euro  Diabetes  Conference
    November  03-05,  2015, Spain
  7. 10th European  Diabetes  Conference
    July  14-16,  2016, UK
  8. 7th Indo Diabetes Conference
    November  23-25,  2015, India
  9. Thyroid Disorders  and treatment Conference
    February 29-March 02, 2016,  USA
  10. 9th Diabetologists Conference
    June 06-08, 2016, USA. 
  11. 2nd  Hormones  and  Steroids  Conference
    June  23-25,  2016, USA
  12. 11th Asia  Pacific  Diabetes  Conference
    July  11-13,  2016, Australia
  13. 12th Diabetes  Conference
    September  29-October  1,  2016,  Canada
  14. 13th Diabetes  Conference 
    August  08-10,  2016, UK
  15. Metabolic Syndrome Conference
    October  20-22,  2016, UAE 
  16. Australasian Diabetes in Pregnancy Society Annual Meeting
  17. 6th Arab Diabetes Forum 2015
  18. European Associations for the Study of Diabetes 51st Annual Meeting
    Sweden
  19. World Congress on Interventional Therapies for Type 2 Diabetes & Diabetes Surgery Summit 2015

Related Societies

  1. American Association of Clinical Endocrinologists
  2. American Association of Endocrine Surgeons
  3. American Diabetes Association
  4. American Society for Bone & Mineral Research
  5. American Society for Reproductive Medicine
  6. American Society of Andrology
  7. American Society of Endocrine Physician Assistants
  8. American Thyroid Association
  9. Androgen Excess and PCOS Society
  10. Association for Program Directors in Endocrinology, Diabetes and Metabolism
  11. Endocrine Nurses Society
  12. International Society for Clinical Densitometry Pediatric Endocrine Society Pediatric. 
  13. Endocrinology Nursing Society
  14. Society for Behavioral Neuroendocrinology
  15. Society for Gynecologic Investigation
  16. Australian Diabetes Society
  17. Society of Biomedical Diabetic Research
  18. Diabetic Society of Singapore
  19. Korean Diabetes Association
  20. Union of Diabetics of Czech Republic

Companies related to Diabetes Medicine

  1. Sanofi-Aventis
  2. Merck & Co., Inc. 
  3. Novo Nordisk
  4. Eli Lilly and Company 
  5. Adley Labs Ltd
  6. EGAN Medical Equipment & Supply
  7. West-Coast pharmaceutical works ltd. 
  8. Takeda Pharmaceuticals
  9. Genzyme
  10. deCODE diabetes medicine
  11. DiabeticCare
  12. AstraZeneca
  13. Bristol-Meyers Squibb
  14. Orban Biotech
  15. SemBioSys
  16. Ceres Chemical Co
  17. signum Biosciences
  18. Proteome Sciences
  19. Centerchem Inc.
  20. Johnson & Johnson Services
  21. Treeline

 

 

This page will be updated regularly.

This page was last updated on 11th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising